Related Experiment Video
Updated: Mar 29, 2026

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
Published on: August 18, 2023
Advancing treatment options for chronic idiopathic constipation.
Eamonn M M Quigley1, Leila Neshatian1
1a Lynda K. and David M. Underwood Center for Digestive Disorders, Division of Gastroenterology and Hepatology , Houston Methodist Hospital, Weill Cornell Medical College , Houston , TX , USA.
Chronic constipation, a widespread issue, is now understood as a syndrome with multiple symptoms. While simple measures help many, novel treatments offer solutions for persistent cases, though defecatory difficulties remain challenging.
Area of Science:
- Gastroenterology
- Digestive Health
- Clinical Therapeutics
Background:
- Chronic constipation is a prevalent global health issue with significant morbidity and societal costs.
- Constipation is now recognized as a complex syndrome, not just infrequent defecation, involving various symptoms like straining and bloating.
Purpose of the Study:
- To review the evolving understanding of constipation and its therapeutic landscape.
- To highlight advancements in treating chronic constipation and identify persistent challenges.
Main Methods:
- Literature review of therapeutic targets and interventions for constipation.
- Analysis of clinical trial outcomes and patient expectations.
Main Results:
- Development of novel prokinetics, prosecretory agents, and bile salt transport inhibitors.
- Limited effective therapies currently exist for anorectal and pelvic floor dysfunction causing defecatory difficulty.
Conclusions:
- Many constipation cases can be managed with simple interventions.
- Novel therapies offer effective and safe options for refractory constipation.
- Defecatory disorders like anismus and pelvic floor dysfunction present ongoing management challenges.
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome III: Medical and Nursing Management
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

